TrademarkDir
DEX-GATI
DEAD

Serial Number

87329838

Owner

Imprimis Pharmaceuticals, Inc.

Attorney

Antony M. Novom

First Use Date

Feb 1, 2017

Filing Date

Feb 9, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

DEX-GATI Trademark

Serial Number: 87329838

DEX-GATI is a trademark filed by Imprimis Pharmaceuticals, Inc. on February 9, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Imprimis Pharmaceuticals, Inc. (123 trademarks)

12264 El Camino Real, Suite 350
San Diego, CA 92130

Entity Type: 03

Trademark Details

Filing Date

February 9, 2017

Registration Date

Not Registered

First Use Anywhere

February 1, 2017

First Use in Commerce

February 1, 2017

Goods & Services

Pharmaceutical compositions for ophthalmological use

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Dec 12, 2018 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 12, 2018 ABN2
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
May 17, 2018 AAUA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 16, 2018 GNRN
NON-FINAL ACTION E-MAILED
May 16, 2018 GNRT
NON-FINAL ACTION WRITTEN
May 16, 2018 CNRT
USE AMENDMENT ACCEPTED
May 16, 2018 IUAA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 12, 2018 TEME
AMENDMENT TO USE PROCESSING COMPLETE
May 12, 2018 AUPC
USE AMENDMENT FILED
May 12, 2018 IUAF
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 11, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 11, 2018 ERFR
TEAS AMENDMENT OF USE RECEIVED
May 11, 2018 EAAU
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 5, 2017 GNFN
FINAL REFUSAL E-MAILED
Dec 5, 2017 GNFR
FINAL REFUSAL WRITTEN
Dec 5, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 17, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 17, 2017 CRFA
ASSIGNED TO LIE
Nov 15, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 3, 2017 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
May 8, 2017 GPRN
PRIORITY ACTION E-MAILED
May 8, 2017 GPRA
PRIORITY ACTION WRITTEN
May 8, 2017 CPRA
ASSIGNED TO EXAMINER
May 3, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 14, 2017 NWOS
NEW APPLICATION ENTERED
Feb 13, 2017 NWAP

Related Trademarks

More from this Owner

HARROWINC

HARROWINC

KLARITY-D

KLARITY-D

KLARITY BASE

KLARITY BASE

KLARITY-B

KLARITY-B

HARROW HEALTH HOLDINGS, INC.

HARROW HEALTH HOLDINGS, INC.

MAYFIELD PHARMACEUTICALS, INC.

MAYFIELD PHARMACEUTICALS, INC.